Evotec SE (EVO) Total Current Liabilities (2009 - 2026)
Evotec SE (EVO) posted Total Current Liabilities of $495663.3 for Q1 2026, up 15.69% sequentially from $428454.2 in Q4 2025, and up 32.02% YoY from $375438.6 in Q1 2025.
Evotec SE (EVO) Total Current Liabilities (2009 - 2026) Analysis & Trends
Evotec SE has reported Total Current Liabilities for 9 years, with the latest figure at $495663.3 in Q1 2026.
- Quarterly Total Current Liabilities rose 32.02% year-over-year to $495663.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $495663.3 (up 32.02% YoY) and the FY2025 annual result came in at $428454.2, down 99.88% from the prior year.
- Total Current Liabilities climbed to $495663.3 in Q1 2026 per EVO's latest filing, from $428454.2 in the prior quarter.
- Over five years, Total Current Liabilities peaked at $499.9 million in Q4 2023 and troughed at $343621.9 in Q3 2022.
- A 5-year average of $110.5 million and a median of $433750.0 in 2025 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities soared 45.08% in 2023, then plunged 99.88% in 2025.
- Over 5 years, Total Current Liabilities stood at $344.5 million in 2022, then jumped by 45.08% to $499.9 million in 2023, then fell by 26.33% to $368.2 million in 2024, then slumped by 99.88% to $428454.2 in 2025, then grew by 15.69% to $495663.3 in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $495663.3, $428454.2, and $437772.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - | 495,663.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 495,663.27 |
| Dec 31, 2025 | 428,454.15 |
| Sep 30, 2025 | 437,772.55 |
| Jun 30, 2025 | 433,749.97 |
| Mar 31, 2025 | 375,438.59 |
| Dec 31, 2024 | 368.22 Mn |
| Sep 30, 2024 | 366,385.79 |
| Dec 31, 2023 | 499.85 Mn |
| Dec 31, 2022 | 344.54 Mn |
| Sep 30, 2022 | 343,621.91 |
| Mar 31, 2022 | 381,168.34 |
| Dec 31, 2021 | 371.24 Mn |
| Sep 30, 2021 | 299,277.18 |
| Dec 31, 2020 | 248.54 Mn |
| Sep 30, 2010 | 35,831.52 |
| Jun 30, 2010 | 32,220.24 |
| Mar 31, 2010 | 32.97 |
| Dec 31, 2009 | 39,052.24 |
| Aug 31, 2009 | 1,102.77 |
| Jun 30, 2009 | 31.95 Mn |